Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 7
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Objective: This study aimed to investigate developmental changes of the thymus and intra- thymic IL-1β, IL-6 and TNF-α expression in weaned Sprague-Dawley rats induced by lipopolysac- charide.

Methods: Forty healthy weaned rats aged 26 days and weighing 83±4 g were randomly and equally divided into two groups. The lipopolysaccharide group was treated daily with a single injection of lipopolysaccharide for 10 consecutive days, and the saline group was treated with an equal volume of sterilized saline. On the 1st, 4th, 7th and 10th day, histological changes and distribu- tion of IL-1β-, IL-6- and TNF-α-positive cells were detected in the thymus by hematoxylin-eosin and immunohistochemistry staining, respectively. Subsequently, the expression levels of IL-1β, IL-6 and TNF-α were evaluated in the thymus by the ELISA method.

Results: Thymus weight and index were significantly smaller in lipopolysaccharide-treated rats than in saline-treated rats (p<0.05), but no substantial changes were found in the thymus microstructure after lipopolysaccharide induction. Moreover, a large number of IL-1β-, IL-6- and TNF-α-positive cells were observed with brownish-yellow color and mainly distributed in the thy- mus parenchyma, both integrated optical density and average optical density increased signifi- cantly in lipopolysaccharide-treated rats than those in saline-treated rats. Compared with the saline group, most of the thymic homogenates had higher levels of IL-1β, IL-6 and TNF-α in the lipopolysaccharide group on different days.

Conclusion: These findings indicate that the thymus atrophied after lipopolysaccharide induction in weaned Sprague-Dawley rats, and excessive production of intrathymic IL-1β, IL-6 and TNF-α was probably involved in the atrophic process.

Go to article

Authors and Affiliations

Y.B. Zhong
X.L. Zhang
M.Y. Lv
X.F. Hu
Y. Li
Download PDF Download RIS Download Bibtex

Abstract

Great economic losses to the dairy industry are associated with bovine mastitis, which results in poor milk quality and high treatment costs. Anti-inflammatory proteins play an important role in the suppression of the immune response against invading pathogenic microorganisms and are therefore being studied for possible use in the early diagnosis of mastitis. In our study, we used milk samples from 15 cows of Holstein Friesian breed with different health status (5 healthy, 5 subclinical, and 5 clinical animals), and tested them using immunohistochemical (IHC) analysis to evaluate the presence of IL-2, IL-10, TGF-β1, βDEF-2, DEF-3, and Cathelicidin LL37 proteins. The calculation of positively and negatively stained cells for each biomarker was performed using the semiquantitative counting method. We found the presence of all factors with the exception of Cathelicidin LL37, which was almost absent in milk samples of all animal groups. The significant decrease of IL-10, β-def2, and β-def3 expression levels within the 3 days of sampling, found in the milk of animals with sub- and clinical mastitis, indicates the loss of antiinflammatory protection of the affected cow’s udder. In contrast, the stable increase of IL-2 and TGF-β1 positive cells observed in the milk of mastitis-affected cows, and the similar expression of these factors in the milk of healthy animals, indicate the possible lack of involvement of these cytokines at an early stage of udder inflammation.
Go to article

Bibliography


Addis MF, Bronzo V, Puggioni GMG, Cacciotto C, Tedde V, Pagnozzi D, Locatelli C, Casula A, Curone G, Uzzau S, Moroni P (2017) Relationship between milk cathelicidin abundance and microbiologic culture in clinical mastitis. J Dairy Sci 100: 2944-2953.
Addis MF, Tedde V, Puggioni GM, Pisanu S, Casula A, Locatelli C, Rota N, Bronzo V, Moroni P, Uzzau S (2016) Evaluation of milk cathelicidin for detection of bovine mastitis. J Dairy Sci 99: 8250-8258.
Alnakip EM, Quintela-Baluja M, Böhme K, Fernández-No I, Caamaño-Antelo S, Calo-Mata P, Barros-Velázquez J (2014) The Immunology of Mammary Gland of Dairy Ruminants between Healthy and Inflammatory Conditions. J Vet Med 2014: 659801.
Alluwaimi AM (2000) Detection of IL-2 and IFN-gamma m RNA expression in bovine milk cells at the late stage of the lactation period with RT-PCR. Res Vet Sci 69: 185-187.
Alluwaimi AM, Cullor JS (2002) Cytokines gene expression patterns of bovine milk during middle and late stages of lactation. J Vet Med B Infect Dis Vet Public Health 49: 105-110.
Alluwaimi AM, Leutenegger CM, Farver TB, Rossitto PV, Smith WL, Cullor JS (2003) The Cytokine Markers in Staphylococcus aureus Mastitis of Bovine Mammary Gland. J Vet Med50: 105-111.
Alhussien MN, Dang AK (2020) Sensitive and rapid lateral- -flow assay for early detection of subclinical mammary infection in dairy cows. Sci Rep Jul 10: 11161.
Anton K, Glod J (2017) Tumor-secreted factors that induce mesenchymal stromal cell chemotaxis. In: Mesenchymal stromal cells as tumor stromal modulators. Academic Press is an imprint of Elsevier, pp 193-214.
Azooz MF, El-Wakeel SA, Yousef HM (2020) Financial and economic analyses of the impact of cattle mastitis on the profitability of Egyptian dairy farms. Vet World 13: 1750-1759.
Bannerman DD (2009) Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J Anim Sci 87 (13 Suppl): 10-25.
Bannerman DD, Paape MJ, Chockalingam A (2006) Staphylococcus aureus intramammary infection elicits increased production of trans-forming growth factor-alpha, beta1, and beta2. Vet Immunol Immunopathol 112: 309-315.
Bannerman DD, Springer HR, Paape MJ, Kauf AC, Goff JP (2008) Evaluation of breed-dependent differences in the innate immune re-sponses of Holstein and Jersey cows to Staphylococcus aureus intramammary infection. J Dairy Res 75: 291-301.
Bartee E, McFadden G (2013) Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine 63: 237-240.
Bochniarz M, Zdzisińska B, Wawron W, Szczubiał M, Dąbrowski R (2017) Milk and serum IL-4, IL-6, IL-10, and amyloid A concentrations in cows with subclinical mastitis caused by coagulase-negative staphylococci. J Dairy Sci 100: 9674-9680.
Britti D, Peli A, Massimini G, Polci A, Luciani A, Famigli-Bergamini P (2005) Evaluation of TNF-alpha, IL-8 and IL-10 transcriptional activity in milk from healthy dairy cows during lactation period. Vet Res Commun 29 (Suppl 2): 281-284.
Chockalingam A, Paape MJ, Bannerman DD (2005) Increased milk levels of transforming growth factor-alpha, beta1, and beta2 during Esch-erichia coli-induced mastitis. J Dairy Sci 88: 1986-1993.
Cheng G, Yu A, Malek TR (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241: 63-76.
Cheng WN, Han SG (2020) Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - A review. Asian-Australas J Anim Sci 33: 1699-1713.
Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121: 1108-1111.
Cubeddu T, Cacciotto C, Pisanu S, Tedde V, Alberti A, Pittau M, Dore S, Cannas A, Uzzau S, Rocca S, Addis MF (2017) Cathelicidin pro-duction and release by mammary epithelial cells during infectious mastitis. Vet Immunol Immunopathol 189: 66-70.
Dallas SL, Alliston T, Bonewald LF (2008) Transforming growth factor-β. In: Principles of bone biology. 2: 1145-1166.
De Vliegher S, Fox LK, Piepers S, McDougall S, Barkema HW (2012) Invited review: Mastitis in dairy heifers: nature of the disease, poten-tial impact, prevention, and control. J Dairy Sci 95:1025-1040.
Dooms H (2013) Interleukin-7: Fuel for the autoimmune attack. J Autoimmun 45 : 40-48.
Eckersall PD (2019) Proteomic approaches to control lactational parameters in dairy cows. Animal 13(S1): s82-s85.
Gauthier SF, Pouliot Y, Maubois JL (2006) Growth factors from bovine milk and colostrum: composition, extraction and biological activities. Lait 86: 99-125.
Gorelik L, Flavell RA (2002) Transforming growth factor- beta in T-cell biology. Nat Rev Immunol 2: 46-53.
Gulbe G, Pilmane M, Saulīte V, Doniņa S, Jermolajevs J, Peškova L, Valdovska A (2020) Cells and Cytokines in Milk of Subclinically Infected Bovine Mammary Glands after the Use of Immunomodulatory Composition GLP 810. Mediators Inflamm 2020: 8238029.
Hettinga K, van Valenberg H, de Vries S, Boeren S, van Hooijdonk T, van Arendonk J, Vervoort J (2011) The host defense proteome of human and bovine milk. PLoS One 6: e19433.
Isobe N, Nakamura J, Nakano H, Yoshimura Y (2009) Existence of functional lingual antimicrobial peptide in bovine milk. J Dairy Sci 92: 2691-2695.
Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, Durum SK (2005) Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 16: 513-533.
Jakiel M, Jesiołkiewicz E, Ptak E (2011): Relationship between somatic cell score and daily milk yield traits of Polish HF cows. Roczniki Naukowe Polskiego Towarzystwa Zootechnicznego 7: 9-17.
Kawai K, Akamatsu H, Obayashi T, Nagahata H, Higuchi H, Iwano H, Oshida T, Yoshimura Y, Isobe N (2013) Relationship between con-centration of lingual antimicrobial peptide and somatic cell count in milk of dairy cows. Vet Immunol Immunopathol 153: 298-301.
Khan MZ, Khan A (2006) Basic facts of mastitis in dairy animals: A review. Pakistan Vet J 26: 204-208.
Kitano N, Isobe N, Noda J, Takahashi T (2020) Concentration patterns of antibacterial factors and immunoglobulin A antibody in foremilk fractions of healthy cows. Anim Sci J 91: e13372.
Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K (2018) Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals. Front Immunol 9: 1364.
Krömker V, Leimbach S (2017) Mastitis treatment-Reduction in antibiotic usage in dairy cows. Reprod Domest Anim 52 (Suppl 3): 21-29.
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev Immunol 19: 683-765.
Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117: 1162-72.
Paudyal S, Pena G, Melendez P, Roman-Muniz IN, Pinedo PJ (2018) Relationships among quarter milk leukocyte proportions and cow and quarter-level variables under different intramammary infection statuses. Transl Anim Science 2: 231-240.
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006) Human beta-defensins. Cell Mol Life Sci 63: 1294-1313.
Petzl W, Zerbe H, Günther J, Yang W, Seyfert HM, Nürnberg G, Schuberth HJ (2008) Escherichia coli, but not Staphylococcus aureus trig-gers an early increased expression of factors contributing to the innate immune defense in the udder of the cow. Vet Res 39: 18.
Pongthaisong P, Katawatin S, Thamrongyoswittayakul C, Roytrakul S (2016) Milk protein profiles in response to Streptococcus agalactiae subclinical mastitis in dairy cows. Anim Sci J 87: 92-98.
Riollet C, Rainard P, Poutrel B (2000) Cells and cytokines in inflammatory secretions of bovine mammary gland. Adv Exp Med Biol 480: 247-158.
Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181.
Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC (2005) Human defensins. J Mol Med (Berl) 83: 587-595.
Schukken YH, Günter J, Fitzpatrick J, Fontaine MC, Goetze L, Holst O, Leigh J, Petzl W, Schuberth HJ, Sipka A, Smith DG, Quesnell R, Watts J, Yancey R, Zerbe H, Gurjar A, Zadoks RN, Seyfert HM, members of the Pfizer mastitis research consortium (2011) Host- -response patterns of intramammary infections in dairy cows. Vet ImmunolImmunopathol 144: 270-289.
Stelwagen K, Carpenter E, Haigh B, Hodgkinson A, Wheeler TT (2009) Immune components of bovine colostrum and milk. J Anim Sci 87 (Suppl 13): 3-9.
Taylor A, Akdis M, Joss A, Akkoç T, Wenig R, Colonna M, Daigle I, Flory E, Blaser K, Akdis CA (2007) IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J. Allergy Clin Immunol 120: 76-83.
Tzavlaki K, Moustakas A (2020) TGF-β Signaling. Biomolecules 10: 487.
Wheeler TT, Smolenski GA, Harris DP, Gupta SK, Haigh BJ, Broadhurst MK, Molenaar AJ, Stelwagen K (2012) Host-defence-related proteins in cows’ milk. Animal 6: 415-22.
Whelehan CJ, Barry-Reidy A, Meade KG, Eckersall PD, Chapwanya A, Narciandi F, Lloyd AT, Farrelly CO (2014) Characterisation and expression profile of the bovine cathelicidin gene repertoire in mammary tissue. BMC Genomics 15: 128.
Wollowski L, Heuwieser W, Kossatz A, Addis MF, Puggioni GMG, Meriaux L, Bertulat S (2021) The value of the biomarkers cathelicidin, milk amyloid A, and haptoglobin to diagnose and classify clinical and subclinical mastitis. J Dairy Sci 104: 2106-2122.
Go to article

Authors and Affiliations

K. Šerstņova
1
M. Pilmane
1
Z. Vitenberga-Verza
1
I. Melderis
1
Ł. Gontar
2
M. Kochański
2
A. Drutowska
2
G. Maróti
3 4
B. Prieto-Simón
5 6

  1. The Institute of Anatomy and Anthropology, RSU, 9 Kronvalda bulvaris, Riga, Latvia
  2. Research and Innovation Centre Pro-Akademia, Innowacyjna 9/11, 95-050 Konstantynow Lodzki, Poland
  3. Seqomics Biotechnology Ltd., Morahalom, Vallalkozak utja 7, Hungary
  4. Biological Research Center, Plant Biology Institute, Szeged, Temesvári krt. 62, Hungary
  5. Department of Electronic Engineering, Universitat Rovira i Virgili, C. de l’Escorxador, 43007 Tarragona, Spain
  6. ICREA, Pg. Lluís Companys 23, Barcelona, Spain
Download PDF Download RIS Download Bibtex

Abstract

Dendritic cells (DCs) due to their ability to present antigens are essential during the immune response to infections. The aim of the study was to evaluate the influence of bovine leukaemia virus (BLV) infection on DC properties. Cytokine profiles of myeloid, plasmacytoid and mono- cyte derived DCs from BLV infected cattle were analysed. Concentrations of IL-6, IL-10, IL-12, IFN-γ, and TNF-α in DC cultures were measured by flow cytometry. Obtained results indicated activation of pDCs population, where a significant increase in production of the IFN-γ was shown. Meanwhile, a decrease in production of IFN-γ and increase in production of IL-10 were shown in mDCs; the main population responsible for antigens presentation. This may indicate a contribu- tory role of the population during the process of persistent infection. In MoDCs population a significant elevation in secretion of proinflammatory cytokines – IL-6 and TNF-α was noted.

Go to article

Authors and Affiliations

E. Iwan
M. Szczotka
J. Kocki
A. Pluta
Download PDF Download RIS Download Bibtex

Abstract

The interstitial cells known as telocytes have been described in various organs. Their role in the normal physiology and pathogenesis of numerous diseases is well known. They have been described in the context of various diseases (gallstone disease, endometriosis, uterine myoma, hydronephrosis, myocardial infraction, psoriasis, etc.), while their impact on inflammation, involvement in angiogenesis, and repair highlights their part in local homeostasis. What is known about their relationship with the immune system? Their secretomes, genome, immune profiles, contacts with surrounding cells, and specific loca-lization allow us to give a possible explanation for their involvement in pathological pathways. This review aims to present the roles and features of telocytes in the context of intestinal immunity (the largest in our body), in the spleen, their interactions with immunocytes, and their place in stem cell niches.
Go to article

Authors and Affiliations

Veronika Aleksandrovych
1
Anna Gil
2
Adrian Poniatowski
1 3

  1. Department of Pathophysiology, Jagiellonian University Medical College, ul. Czysta 18, 31-121 Kraków, Poland
  2. Department of Anatomy, Jagiellonian University Medical College, ul. Kopernika 12, 31-034 Kraków, Poland
  3. Vassar Brothers Medical Center, Department of Medicine, 45 Reade Place, Poughkeepsie, NY, USA
Download PDF Download RIS Download Bibtex

Abstract

This study aimed to assess the clinical efficacy of pentoxifylline (PTX) and L-glutamine (L-Gln) treatment on ischemia and reperfusion (I/R) injury in the abomasal tissue, acute phase response (APR), oxidative stress (OS), cytokine response, hemostatic, and coagulation disorders in the 96-h period before and after surgery in displaced abomasum (DA) cases. The study sample consisted of 48 dairy cows with DA that were categorized into four groups as group S (Sham group) (9 Left displaced abomasum (LDA)+3 Right displaced abomasum (RDA), group P (PTX) (10 LDA+2 RDA), group G (L-Gln) (10 LDA+2 RDA), and group P+G (PTX+L-Gln) (10 LDA+2 RDA). Acute-phase protein (Haptoglobin), oxidative stress indicators (malondialdehyde, nitric oxide, and glutathione), cytokines (tumor necrosis factor (TNF)-α and interleukin-1β (IL-1β), coagulation factors (D-Dimer, Antithrombin (ATIII), Thrombin-antithrombin complex, Plasminogen activator inhibitor-1), and enzyme activities (lactate dehydrogenase, gamma- -glutamyl transferase, sorbitol dehydrogenase, glutamate dehydrogenase, adenosine deaminase, myeloperoxidase, and creatine phosphokinase) in blood serum samples and coagulometric analyses of blood plasma were performed in samples taken before the operation and at 30 and 60 min and 2, 5, 10, 24, 48, 72, and 96 h after the operation. In DA cases, while post-operative treatment procedures with PTX and L-Gln were effective in decreasing APR and OS, these were ineffective in prohibiting the inflammatory response coordinated by cytokines. For the treatment and prevention of I/R injury in the DA cases, PTX and L-Gln procedures hold promise with their effects on APR, OS, and hemostatic dysfunction. Additional treatment procedures are required for the suppression of inflammatory response, and the effectiveness of preconditioning treatment may be evaluated.
Go to article

Bibliography


Abilés J, Moreno-Torres R, Moratalla G, Castaño J, Pérez Abúd R, Mudarra A, Machado Ma J, Planells E, Pérez de la Cruz A (2008) Effects of supply with glutamine on antioxidant system and lipid peroxidation in patients with parenteral nutrition. Nutr Hosp 23: 332-339.

Acosta S, Bjorck M (2003) Acute thrombo-embolic occlusion of the superior mesenteric artery: a prospective study in a well-defined population. Eur J Vasc Endovasc 26: 179-183.

Altinyollar H, Boyabatli M, Berberoglu U (2006) D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb Res 117: 463-467.

An ZM, Dong XG, Guo Y, Zhou JL, Qin T (2015) Effects and clinical significance of pentoxifylline on the oxidative stress of rats with dia-betic nephropathy. Huazhong Univ Sci Technolog Med Sci 35: 356-361.

Bian GX, Li GG, Yang Y, Liu RT, Ren JP, Wen LQ, Guo SM, QJ Lu (2008) Madecassoside reduces ischemia-reperfusion injury on regional ischemia induced heart infarction in rat. Biol Pharm Bull 31: 458-463.

Bick RL (1994) Disseminated intravascular coagulation: objective criteria for diagnosis and management. Med Clin N Am 78: 511-543.

Cano CP, Bermudez VP, Atencio HE, Medina MT, Anilsa A, Souki A, Molina OM, Restrepo H, Vargas ME, Núñez M, Ambard M, Toledo A, Contreras F, Velasco M (2003) Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset. Am J Ther 10: 473-476.

Cevrioglu AS, Yilmaz S, Koken T, Tokyol C, Yilmazer M, Fenkci IV (2004) Comparison of the effects of low intra-abdominal pressure and ischaemic preconditioning on the generation of oxidative stress markers and inflammatory cytokines during laparoscopy in rats. Hum Reprod 19: 2144-2151.

Cöl R, Durgun Z (2011) Effect of recombinant interleukin-10 on some haematological and biochemical parameters in a rat endotoxaemic mod-el. Acta Vet Hung 59: 237-245.

Collatos C, Barton MH, Schleef R, Prasse KW, Moore JN (1994) Regulation of equine fibrinolysis in blood and peritoneal fluid based on a study of colic cases and induced endotoxaemia. Equine Vet J 26: 474-481.

Constable PD, Miller GY, Hoffsis GF, Hull BL, Rings DM (1992a) Risk factors for abomasal volvulus and left abomasal displacement in cattle. Am J Vet Res 53: 1184-1192.

Constable PD, St-Jean G, Koenig GR, Hull BL, Rings DM (1992b) Abomasal luminal pressure in cattle with abomasal volvulus or left dis-placed abomasum. J Am Vet Med Assoc 201: 1564-1568.

Corum O, Corum DD, Atik O, Er A, Uney K (2019) Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after intravenous administration of increasing doses to sheep. Am J Vet Res 80: 702-708.

Coster J, McCauley R, Hall J (2004) Glutamine: metabolism and application in nutrition support. Asia Pacific J Clin Nutr 13: 25-31.

Delgado MA, Monreal L, Armengou L, Ríos J, Segura D (2009) Peritoneal D-dimer concentration for assessing peritoneal fibrinolytic activity in horses with colic. J Vet Intern Med 23: 882-889.

Di Loria A, Piantedosi D, Cortese L, Roperto S, Urraro C, Paciello O. Guccione J, Britti D, Ciaramella P (2012) Clotting profile in cattle showing chronic enzootic haematuria (CEH) and bladder neoplasms. Res Vet Sci 93: 331-335.

Doll K (2015) Abomasal displacement in dairy cattle: a hereditary disease?. Vet J 205: 329-330.

Doll K, Sickinger M, Seeger T (2009) New aspects in the pathogenesis of abomasal displacement. Vet J 181: 90-96.

El-Ghoneimi A, Cursio R, Schmid-Alliana A, Tovey M, Lasfar A, Michiels JF, Rossi B, Gugenheim J (2007) Inhibition of tumor necrosis factor alpha gene transcription by pentoxifylline reduces normothermic liver ischemia-reperfusion injury in rats. Transplant Proc 39: 1761-1764.

Estrin MA, Wehausen CE, Jessen CR, Lee JA (2006) Disseminated intravascular coagulation in cats. J Vet Intern Med 20: 1289-1290.

Fürll M, Dabbagh MN, Fürll B, Sattler T (2004) The behaviour of superoxide dismutase (SOD) in serum of cows with abomasal displace-ment (DA). Dtsch Tierarztl Wochenschr 111: 7-13.

Gando S, Hayakawa M (2016) Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost 42: 155-165.

Geishauser T (1995) Abomasal displacement in the bovine a review on character, occurrence, aetiology and pathogenesis. Zentralbl Veteri-naermed A 42: 229-251.

Grosche A, Fürll M, Wittek T (2012) Peritoneal fluid analysis in dairy cows with left displaced abomasum and abomasal volvulus. Vet Rec 170: 413.

Guiqi G (2011) Pre-treatment with glutamine attenuates lung injury in rats subjected to intestinal ischaemia-reperfusion. Injury 42: 72-77.

Hammerman C, Goldschmidt D, Caplan MS, Kaplan M, Schimmel MS, Eidelman AI, Branski D, Hochman A (1999) Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Pediatr Gastr Nutr 29: 69-74.

Hirvonen J, Pyörala S. (1998) Acute-phase response in dairy cows with surgically-treated abdominal disorders. Vet J 155: 53-61.

Ikeda S, Zarzaur BL, Johnson CD, Fukatsu K, Kudsk KA (2002) Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia/reperfusion. Jpen-Parenter Enter 26: 169-173.

Irmak K, Turgut K (2005) Disseminated intravascular coagulation in cattle with abomasal displacement. Vet Res Commun 29: 61-68.

Jaillardon L, Barthélemy A, Goy-Thollot I, Pouzot-Nevoret C, Fournel-Fleury C (2012) Mammary gland carcinoma in a dog with peripheral blood and bone marrow involvement associated with disseminated intravascular coagulation. Vet Clin Pathol 41: 261-265.

Jurczuk M, Brzoska MM, Moniuszko-Jakoniuk J (2007) Hepatic and renal concentrations of vitamins E and C in lead and ethanol-exposed rats. an assessment of their involvement in the mechanisms of peroxidative damage. Food Chem Toxicol 45: 1478-1486.

Karakurum MÇ, Albay MK, Şahinduran Ş, Sezer K (2009) Coagulation parameters in cattle with left displacement of abomasum. Kafkas Univ Vet Fak Derg 15: 293-296.

Karatepe O, Gulcicek OB, Ugurlucan M, Adas G, Battal M, Kemik A, Kamali G, Altug T, Karahan S (2009) Curcumin nutrition for the prevention of mesenteric ischemia-reperfusion injury: an experimental rodent model. Transplant Proc 41: 3611-3616.

Kayano M, Kida K (2015) Identifying alterations in metabolic profiles of dairy cows over the past two decades in Japan using principal component analysis. J Dairy Sci 98: 8764-8774.

Kloek J, Levi M, Heger M (2010) Cholestasis enhances liver ischemia/reperfusion-induced coagulation activation in rats. Hepatol Res 40: 204-215.

Levi M, van der Poll T (2010) Inflammation and coagulation. Crit Care Med 38: 26-34.

Maden M, Ozturk AS, Bulbul A, Avci GE, Yazar E (2012) Acute-phase proteins, oxidative stress, and enzyme activities of blood serum and peritoneal fluid in cattle with abomasal displacement. J Vet Intern Med 26: 1470-1475.

Maden M, Yildiz R, Çöl R, Arican M, Ider M, Garip M, Tras B (2018) The evaluation of hemostatic dysfunctionand disseminated intravas-cular coagulationin dairy cows with abomasal displacement. Pol J Vet Sci 21: 769-778.

Mallick IH, Yang W, Winslet MC, Seifalian AM (2004) Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 49: 1359-1377.

Moreira CN, Souza SN, Barini AC, Araújo EG, Fioravanti MCS (2012) Serum γ-glutamyltransferase activity as an indicator of chronic liver injury in cattle with no clinical signs. Arq Bras Med Vet Zootec 64: 1403-1410.

Ogurtan Z, Izci C, Ceylan C, Ok M (2003) Activated partial thromboplastin time and prothrombin time in cows with left displacent of aboma-sum. Indian Vet J 80: 429-431.

Ok M, Şen İ, Güzelbekteş H, Boydak M, Er C, Aydogdu U, Yildiz R (2013) The importance of concentrations of sorbitol dehydrogenase and glutamate dehydrogenase and B-Mode ultrasonographic examination in the diagnosis of hepatic lipidosis in dairy cows. Kafkas Univ Vet Fak Derg 19: 117-123.

Pyörala S, Kokkonen T, Pyörala E (1993) Bovine intestinal surgery in field conditions. Part III. Patients submitted to the Ambulatory Clinic of the College of Veterinary Medicine (1981-1992) a retrospective study. Finnish Veterinary Journal 99: 374-380.

Radwińska J (2010) Effect of the BVD-MD virus on coagulation and fibrinolytic systems in dairy cows. Bull Vet Isnt Pulawy 54: 293-298.

Reeves MJ, Vansteenhouse J, Stashak TS, Yovich JV, Cockerell G (1990) Failure to demonstrate reperfusion injury following ischaemia of the equine large colon using dimethyl sulphoxide. Equine Vet J 22: 126-132.

Roland L, Drillich M, Iwersen M (2014) Hematology as a diagnostic tool in bovine medicine. J Vet Diagn Invest 26: 592-598.

Sener G, Akgun U, Satıroğlu H, Topaloğlu U, Keyer-Uysal M (2001) The effect of pentoxifylline on intestinal ischemia/reperfusion injury. Fund Clin Pharmacol 15: 19-22.

Sexton MF, Buckley W, Ryan E (2007) A study of 54 cases of left displacement of the abomasum. Ir Vet J 60: 605-609.

Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-295.

Sobiech P, Radwińska J, Krystkiewicz W, Snarska A, Stopyra A (2008) Changes in the coagulation profile of cattle with left abomasal displacement. Pol J Vet Sci 11: 301-306.

Sobiech P, Rekawek W, Ali M, Targoński R, Zarczyńska K, Snarska A, Stopyra A (2013) Changes in blood acid-base balance parameters and coagulation profile during diarrhea in calves. Pol J Vet Sci 16: 543-549.

Sørensen JV (1996) Haemostatic activation after surgery and trauma, relationship to clinicopathological findings. Thesis, 1996. Aarhus Uni-versitet, Denmark.

Souza DG, Ferreira FL, Fagundes CT, Amaral FA, Vieira AT, Lisboa RA, Andrade MVM, Trifilieff A, Teixeira MM (2007) Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol 571: 72-80.

Stojević Z, Piršljin J, Milinković-Tur S, Zdelar-Tuk M, Beer Ljubić B (2005) Activities of AST, ALT and GGT in clinically healthy dairy cows during lactation and in the dry period. Veterinarski Arhiv 75: 67-73.

Stokol T (2012) Laboratory diagnosis of disseminated intravascular coagulation in dogs and cats: the past, the present, and the future. Vet Clin North Am Small Anim Pract 42: 189-202.

Tazuke Y, Wasa M, Shimizu Y, Wang HS, Okada A (2003) Alanyl-glutamine-supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats. Jpen J Parenter Enteral Nutr 27: 110-115.

Uney K, Tras B, Corum O, Yildiz R, Maden M (2019) Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite following intra-venous administration in cattle. Trop Anim Health Prod 51: 435-441.

Van Winden SC, Kuiper R (2003) Left displacement of the abomasum in dairy cattle: recent developments in epidemiological and etiological aspects. Vet Res 34: 47-56.

Wasa M, Soh H, Shimizu Y, Fukuzawa M (2005) Glutamine stimulates amino acid transport during ischemia- reperfusion in human intestinal epithelial cells. J Surg Res 23: 75-81.

Wittek T, Grosche A, Locher LF, Fürll M (2010) Diagnostic accuracy of D-dimer and other peritoneal fluid analysis measurements in dairy cows with peritonitis. J Vet Intern Med 24: 1211-1217.

Zadnik TA (2003) Comparative study of the hemato-biochemical parameters between clinically healthy cows and cows with displacement of the abomasum. Acta Vet Beograd 53: 297-309.

Zhang F, Tong L, Qiao H, Dong X, Qiao G, Jiang H, Sun X (2008) Taurine attenuates multiple organ injury induced by intestinal ischemia reperfusion in rats. J Surg Res 149: 101-109.
Go to article

Authors and Affiliations

M. Maden
1
R. Yildiz
2
R. Çöl
3
M. Arican
4
M. Ider
1
K. Parlak
4
B. Tras
5

  1. Department of Internal Medicine, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey
  2. Department of Internal Medicine, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, 15030, Burdur, Turkey
  3. Department of Physiology, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey
  4. Department of Surgery, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey
  5. Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey
Download PDF Download RIS Download Bibtex

Abstract

Due to the unrecognized effect of tigecycline (TIG) on CD4+ and CD8+ T cells, the present study has been undertaken in order to determine whether the drug can affect these cells in respect of their counts, and the production of IFN-γ, IL-17 (pro-inflammatory and immune-protective cytokines), IL-4 (anti-inflammatory and immune-protective cytokine), IL-10 and TGF-β (anti-inflammatory and immune-suppressive cytokines). Murine lymphocytes were treated with TIG for 48 and 96 h at concentrations reflecting its plasma levels obtained in vivo at therapeutic doses, and at 10-fold lower concentrations. It was found that TIG neither affected substantially the percentage and absolute counts of entire CD4+ and CD8+ T cell populations nor influenced the Foxp3+CD25+CD4+ regulatory/suppressive T cell subset. Furthermore, the percentages of IL-4-, IL-10-, IL-17- and TGF-β-producing CD4+ T cells were not altered following the exposure to TIG. Similarly, TIG did not influence IFN-γ production by CD8+ T cells. Thus, with respect to the parameters evaluated, TIG does not seem to exert immune-suppressive and anti-inflammatory effects.

Go to article

Authors and Affiliations

A. Jasiecka-Mikołajczyk
J.J. Jaroszewski
T. Maślanka
Download PDF Download RIS Download Bibtex

Abstract

This study aimed to develop an equine-derived hyperimmune serum against SARS-CoV-2 and evaluate its efficacy as a potential immunotherapy tool for the treatment of known and potential variants of COVID-19 in preclinical trials.
The novelty of this study is the whole virus and ALUM gel adjuvant formula. The horses were immunized using a whole inactivated SARS-CoV-2 antigen, and the final purified hyperimmune serum showed high plaque reduction neutralization (PRNT 50) neutralizing titers. The efficacy of the hyperimmune serum was evaluated histopathologically and biochemically in the lungs, hearts, and serum of K18 hACE2 transgenic mice (n=45), which is an accepted model organism for SARS-CoV-2 studies and was challenged with live SARS-CoV-2.
Serum treatment improved the general condition, resulting in lower levels of proinflammatory cytokines in the blood plasma, as well as reduced viral RNA titers in the lungs and hearts. Additionally, it reduced oxidative stress significantly and lessened the severity of interstitial pneumonia in the lungs when compared to infected positive controls.
The study concluded that equine-derived anti-SARS-CoV-2 antibodies could be used for COVID-19 prevention and treatment, especially in the early stages of the disease and in combination with antiviral drugs and vaccines. This treatment will benefit special patient populations such as immunocompromised individuals, as specific antibodies against SARS-CoV-2 can neutralize the virus before it enters host cells. The rapid and cost-effective production of the serum allows for its availability during the acute phase of the disease, making it a critical intervention in preventing the spread of the disease and saving lives in new variants where a vaccine is not yet developed.
Go to article

Bibliography

1. Botosso VF, Jorge SAC, Astray RM, Guimaraes AMS, Mathor MB, Carneiro PS, Durigon EL, Covas D, Oliveira DBL, Oliveira RN, Maria DA, Eto SF, Gallina NMF, Pidde G, Squaiella-Baptistão CS, Silva DT, Villas-Boas IM, Fernandes DC, Auada AVV, Banari AC, Filho AFS, Bianconi C, Utescher CLA, Oliveira DCA, Mariano DOC, Barbosa FF, Rondon G, Kapronezai J, Silva J G, Goldfeder MB, Comone P, Junior REC, Pereira TTS, Wen FH, Tambourgi DV, Chudzinski-Tavassi AM (2022) Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Sci Rep 12: 3890.
2. De Vito A, Colpani A, Saderi L, Puci M, Zauli B, Fiore V, Fois M, Meloni MC, Bitti A, Di Castri C, Maida I, Babudieri S, Sotgiu G, Madeddu G. (2022) Impact of early SARS-CoV-2 antiviral therapy on disease progression. Viruses 15: 71.
3. Dong W, Mead H, Tian L, Park JG, Garcia JI, Jaramillo S, Barr T, Kollath DS, Coyne VK, Stone NE, Jones A, Zhang J, Li A, Wang LS, Milanes-Yearsley M, Torrelles JB, Martinez-Sobrido L, Keim PS, Barker BM, Caligiuri MA, Yu J (2022) The K18-Human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J Virol: e0096421.
4. Golden JW, Cline CR, Zeng X, Garrison AR, Carey BD, Mucker EM, White LE, Shamblin JD, Brocato RL, Liu J, Babka AM, Rauch HB, Smith JM, Hollidge BS, Fitzpatrick C, Badger CV, Hooper JW (2020) Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 5: e142032.
5. Jha A, Barker D, Lew J, Manoharan V, Kessel JV, Haupt R, Toth D, Frieman M, Falzarano D, Kodihalli S (2022) Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection. Sci Rep 12: 16956.
6. León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura A, Gómez A, Solano G, Aguilar E C, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gu-tiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A (2021) Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. Sci Rep 11: 9825.
7. Li E, Han Q, Bi J, Wei S, Wang S, Zhang Y, Liu J, Feng N, Wang T, Wu J, Yang S, Zhao Y, Liu B, Yan F, Xia X (2023) Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection. Front Immunol 14: 1066730.
8. Luis Eduardo Cunha, Stolet AA, Strauch MA, Pereira VAR, Dumard CH, Gomes AMO, Souza PNC, Fonseca JG, Pontes FE, Meirelles LGR, Albuquerque JWM, Sacramento CQ, Rodrigues NF, Lima TM, Alvim RGF, Marsili FF, Caldeira MM, Higa LM, Monteiro FL, Zingali RB, Oliveira GAP, Souza TML, Tanuri A, Oliveira AC, Guedes H L M, Castilho L R , Silva J L (2020) Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy. Cold Spring Harbor Laboratory, bioRxiv 17: 254375
9. Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 (2021) Leads to a small vessel endotheliitis in the heart. EBioMedicine 63: 103182.
10. Moreira-Soto A, Arguedas M, Brenes H, Buján W, Corrales-Aguilar E, Díaz C, Echeverri A, Flores-Díaz M, Gómez A, Hernández A, Herrera M, León G, Macaya R, Kühne A, Molina-Mora JA, Mora J, Sanabria A, Sánchez A, Sánchez L, Segura Á, Segura E, Solano D, Soto C, Stynoski JL, Vargas M, Villalta M, Reusken CBEM, Drosten C, Gutiérrez JM, Alape-Girón A, Drexler JF (2021) High efficacy of therapeutic equine hyperimmune antibodies against SARS-CoV-2 variants of concern. Frontiers in Medicine. 8: 735853.
11. Onen EA, Sonmez K, Yildirim F, Demirci EK, Gurel A (2022) Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease. All Life 15: 771-793.
12. Pan X, Zhou P, Fan T, Wu Y, Zhang J, Shi X, Shang W, Fang L, Jiang X, Shi J, Sun Y, Zhao S, Gong R, Chen Z, Xiao G (2020) Im-munoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Res 182: 104868.
13. Schoell A, Heyde B, Weir D, Po-Chang C, Yiding H, Tung D (2009) Euthanasia method for mice in rapid time-course pulmonary. Pharmacokinetic Studies 48: 506.
14. Suvarna KS, Layton C, Bancroft JD (2018) Bancroft’s theory and practice of histological techniques E-Book. Elsevier health sciences, Philadelphia, pp 286-291.
15. Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, Ritter JH, Kang L, Dort S, Robichaud A, Head R, Holtzman MJ, Diamond MS (2020) SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21: 1327-1335.
16. Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G (2020) SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir Res 21: 182.
17. Yu P, Deng W, Bao L, Qu Y, Xu Y, Zhao W, Han Y, Qin C (2022) Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2. Vet Pathol 59: 602-612.
18. Zhang Q, Wang Y, Qi C, Shen L, Li J (2020) Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol 92: 540-545.

Go to article

Authors and Affiliations

E.A. Onen
1
E.K. Demirci
2

  1. Kocak Pharmaceutical Company, Biotechnology and Vaccine R&D, Tekirdag, Turkey
  2. Histology and Embryology Department, Istanbul Faculty of Medicine,Istanbul University, Istanbul, Turkey

This page uses 'cookies'. Learn more